Study finds that bowel cancer screening is exceptionally beneficial
Bowel cancer screening has an exceptionally favourable benefit-to-harm balance, according to new research published in Public Health... Read More
LIBERATE trial could be key to accurate cancer mutation screening
The LIBERATE study has reached its target of 100 participants, and is now in follow up. LIBERATE is... Read More
RoLaCaRT: Could using robots lead to more successful surgeries?
Using a robot rather than keyhole surgery could lead to a higher rate of successful surgeries for people... Read More
Highlights from the ASCO Annual Meeting
The ASCO Annual Meeting is the world’s largest oncology conference. In 2019, more than 30,000 people attended the... Read More
Introducing Research Fellow Dr Zarka Samoon
The GI Cancer Institute has welcomed its newest Clinical Research Fellow, Dr Zarka Samoon. She is a medical oncologist... Read More
Neglected Cancers Getting the Attention they Deserve
In recognising Neglected Cancers Awareness Week, on Friday 21 June, 40 of Australia’s leading researchers, medical professionals... Read More
Introducing AGITG Research Fellow Dr Zarka Samoon
The AGITG has welcomed its newest Clinical Research Fellow, Dr Zarka Samoon. She is a medical oncologist and Oncology... Read More
Rare Cancers – It’s Personal – Trine Simpson’s Story
Highlighting Stomach Cancer with the Silly Hat for Matt Challenge In 2018 Trine Simpson and her friends, set up... Read More
Neglected Cancer Awareness Week 17-23 June
This week is Neglected Cancers’ Awareness Week – bringing attention to those rare and less common cancers that... Read More
Preliminary results for ALT-GIST released
The preliminary results of the ALT-GIST clinical trial have been released at the ASCO Annual Meeting. ALT-GIST investigated the... Read More
Report from the COSA Cancer Survivorship Conference: Jan Mumford & Robin Mitchell
The Clinical Oncology Society of Australia (COSA) Cancer Survivorship Conference was held from 28-29 March. The event hosted... Read More
Could liquid biopsies be the future of cancer detection?
People with advanced cancer are using new technology to detect cancer recurrence or the mutation status of tumours.... Read More
Jim Kershaw: Beating the odds against GI cancer
Clinical trials save lives: Support our research Jim Kershaw started to feel... Read More
RANDOMS: Measuring the impact of malnutrition
Image: Dietitian Belinda Steer. A new study will aim to find the best tool to measure malnutrition for pancreatic... Read More
The first Japanese site in an AGITG trial opens for INTEGRATE II
The first AGITG trial site in Japan has opened for the INTEGRATE II study in gastro-oesophageal cancer. National Cancer... Read More
How the GI Cancer Institute’s research is developed
The GI Cancer Institute’s research and clinical trials are developed through a robust, scientific process. The studies we... Read More
Our Clinical Trials: Colorectal Cancer
March is Colorectal Cancer Awareness Month, and the GI Cancer Institute is joining people and organisations worldwide to... Read More
Breaking new ground in exercise and colorectal cancer treatment
Exercise can have significant benefits for cancer treatment and recovery, and new research is discovering the full extent... Read More
First patient enrolled in RENO
The RENO study has activated its first site and the first patient has been enrolled in the study.... Read More